Top

Clinical Orthopaedics and Related Research®

Published in:

01-10-2013 | Clinical Research

Incidence and Risk Factors for Pulmonary Embolism After Primary Musculoskeletal Tumor Surgery

Authors: Koichi Ogura, MD, Hideo Yasunaga, MD, PhD, Hiromasa Horiguchi, PhD, Kazuhiko Ohe, MD, PhD, Hirotaka Kawano, MD, PhD

Published in: Clinical Orthopaedics and Related Research® | Issue 10/2013

Abstract

Background

Limited information is available regarding the incidence, risk factors, and optimal prophylaxis in orthopaedic oncology patients, although malignancy and major orthopaedic surgery are associated with an increased pulmonary embolism (PE) risk.

Questions/purposes

We aimed to investigate the incidence of PE after musculoskeletal tumor surgery in Japanese patients and analyze the potential risk factors for PE.

Methods

We retrospectively identified 3750 patients (1981 males, 1769 females) who underwent musculoskeletal tumor surgery during 2007 to 2010 using the Japanese Diagnostic Procedure Combination administrative database. Data collected included sex, age, primary diagnosis, type of surgery, duration of anesthesia, and comorbidities that may affect PE incidence. Univariate logistic regression analyses were performed to examine the relationship of each factor with PE occurrence.

Results

We identified 10 patients with PE during the survey period. A primary malignant bone tumor was associated with a significantly higher risk of PE than a primary malignant soft tissue tumor (odds ratio [OR], 5.58; 95% CI, 1.39–22.42). Bone tumor resection (OR, 7.94; 95% CI, 1.77–35.59) and prosthetic reconstruction (OR, 9.15; 95% CI, 1.52–55.07) were associated with a significantly higher risk of PE than soft tissue tumor resection.

Conclusions

Malignant bone tumors and bone tumor resections have a higher risk of PE than malignant soft tissue neoplasms and soft tissue resections. Both populations might require PE prophylaxis as it is likely that the risk is greater than with other major orthopaedic surgery, but data accumulation should continue, and further investigation should be done to clarify details of the incidence, risk factors, and optimal prophylaxis for PE.

Level of Evidence

Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.

Athale U, Cox S, Siciliano S, Chan AK. Thromboembolism in children with sarcoma. Pediatr Blood Cancer. 2007;49:171–176.PubMedCrossRef

Benevenia J, Bibbo C, Patel DV, Grossman MG, Bahramipour PF, Pappas PJ. Inferior vena cava filters prevent pulmonary emboli in patients with metastatic pathologic fractures of the lower extremity. Clin Orthop Relat Res. 2004;426:87–91.PubMedCrossRef

Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis. Ann Surg. 1988;208:227–240.PubMedCrossRef

Damron TA, Wardak Z, Glodny B, Grant W. Risk of venous thromboembolism in bone and soft-tissue sarcoma patients undergoing surgical intervention: a report from prior to the initiation of SCIP measures. J Surg Oncol. 2011;103:643–647.PubMedCrossRef

Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 suppl):381S–453S.

Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB. Prevention of venous thromboembolism. Chest. 2001;119(1 suppl):132S–175S.PubMedCrossRef

Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809–815.PubMedCrossRef

Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Buller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol. 2000;18:3078–3083.PubMed

Japanese Orthopaedic Association Musculoskeletal Tumor Committee. Bone and Soft Tissue Tumor Registry in Japan. Tokyo, Japan: National Cancer Center; 2009.

10.

Kadono Y, Yasunaga H, Horiguchi H, Hashimoto H, Matsuda S, Tanaka S, Nakamura K. Statistics for orthopedic surgery 2006–2007: data from the Japanese Diagnosis Procedure Combination database. J Orthop Sci. 2010;15:162–170.PubMedCrossRef

11.

Kitamukai O, Sakuma M, Takahashi T, Kagaya Y, Watanabe J, Shirato K. Incidence and characteristics of pulmonary thromboembolism in Japan 2000. Intern Med. 2003;42:1090–1094.PubMedCrossRef

12.

Leonardi MJ, McGory ML, Ko CY. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality. Ann Surg Oncol. 2007;14:929–936.PubMedCrossRef

13.

Lin PP, Graham D, Hann LE, Boland PJ, Healey JH. Deep venous thrombosis after orthopedic surgery in adult cancer patients. J Surg Oncol. 1998;68:41–47.PubMedCrossRef

14.

Masuda K, Chikuda H, Yasunaga H, Hara N, Horiguchi H, Matsuda S, Takeshita K, Kawaguchi H, Nakamura K. Factors affecting the occurrence of pulmonary embolism after spinal surgery: data from the national administrative database in Japan. Spine J. 2012;12:1029–1034.PubMedCrossRef

15.

Mismetti P, Laporte S, Zufferey P, Epinat M, Decousus H, Cucherat M. Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis. J Thromb Haemost. 2004;2:1058–1070.PubMedCrossRef

16.

Mitchell SY, Lingard EA, Kesteven P, McCaskie AW, Gerrand CH. Venous thromboembolism in patients with primary bone or soft-tissue sarcomas. J Bone Joint Surg Am. 2007;89:2433–2439.PubMedCrossRef

17.

Moore FD Jr, Osteen RT, Karp DD, Steele G Jr, Wilson RE. Anticoagulants, venous thromboembolism, and the cancer patient. Arch Surg. 1981;116:405–407.PubMedCrossRef

18.

Morii T, Mochizuki K, Tajima T, Aoyagi T, Satomi K. Venous thromboembolism in the management of patients with musculoskeletal tumor. J Orthop Sci. 2010;15:810–815.PubMedCrossRef

19.

Nagase Y, Yasunaga H, Horiguchi H, Hashimoto H, Shoda N, Kadono Y, Matsuda S, Nakamura K, Tanaka S. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan. J Bone Joint Surg Am. 2011;93:e146.PubMedCrossRef

20.

Nathan SS, Simmons KA, Lin PP, Hann LE, Morris CD, Athanasian EA, Boland PJ, Healey JH. Proximal deep vein thrombosis after hip replacement for oncologic indications. J Bone Joint Surg Am. 2006;88:1066–1070.PubMedCrossRef

21.

Park B, Messina L, Dargon P, Huang W, Ciocca R, Anderson FA. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest. 2009;136:983–990.PubMedCrossRef

22.

Patel AR, Crist MK, Nemitz J, Mayerson JL. Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients. J Surg Oncol. 2010;102:276–281.PubMedCrossRef

23.

Paz-Priel I, Long L, Helman LJ, Mackall CL, Wayne AS. Thromboembolic events in children and young adults with pediatric sarcoma. J Clin Oncol. 2007;25:1519–1524.PubMedCrossRef

24.

Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100:3484–3488.PubMedCrossRef

25.

Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.PubMedCrossRef

26.

Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev. 1992;11:237–248.PubMedCrossRef

27.

Tuy B, Bhate C, Beebe K, Patterson F, Benevenia J. IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery. Clin Orthop Relat Res. 2009;467:239–245.PubMedCrossRef

28.

Yasunaga H, Yanaihara H, Fuji K, Horiguchi H, Hashimoto H, Matsuda S. Impact of hospital volume on postoperative complications and in-hospital mortality after renal surgery: data from the Japanese Diagnosis Procedure Combination Database. Urology. 2010;76:548–552.PubMedCrossRef

Title: Incidence and Risk Factors for Pulmonary Embolism After Primary Musculoskeletal Tumor Surgery
Authors: Koichi Ogura, MD
Hideo Yasunaga, MD, PhD
Hiromasa Horiguchi, PhD
Kazuhiko Ohe, MD, PhD
Hirotaka Kawano, MD, PhD
Publication date: 01-10-2013
Publisher: Springer US
Published in: Clinical Orthopaedics and Related Research® / Issue 10/2013
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI: https://doi.org/10.1007/s11999-013-3073-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Incidence and Risk Factors for Pulmonary Embolism After Primary Musculoskeletal Tumor Surgery

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Level of Evidence

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Level of Evidence

Please log in to get access to this content

Other articles of this Issue 10/2013

Complication Rates After Hip or Knee Arthroplasty in Morbidly Obese Patients

Professional Liability in Orthopaedics and Traumatology in Italy

Outcome of One-stage Cementless Exchange for Acute Postoperative Periprosthetic Hip Infection

CORR Insights®: Outcome of One-stage Cementless Exchange for Acute Postoperative Periprosthetic Hip Infection

Staphylococcus aureus Colonization among Arthroplasty Patients Previously Treated by a Decolonization Protocol: A Pilot Study

CORR Insights®: How Useful is MRI in Diagnosing Isolated Bundle ACL Injuries?